The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Survival following implementation of next-generation sequencing in routine diagnostics of advanced lung cancer: Results of the German Network Genomic Medicine.
 
Anna Kostenko
No Relationships to Disclose
 
Sebastian Yves Friedrich Michels
No Relationships to Disclose
 
Jana Fassunke
No Relationships to Disclose
 
Matthias Scheffler
Consulting or Advisory Role - Boehringer Ingelheim (Inst); Bristol-Myers Squibb; Novartis (Inst)
Speakers' Bureau - AstraZeneca; Novartis; Roche Pharma AG
 
Sabine Merkelbach-Bruse
No Relationships to Disclose
 
Rieke Nila Fischer
Consulting or Advisory Role - Bristol-Myers Squibb (Inst)
Speakers' Bureau - Boehringer Ingelheim; Bristol-Myers Squibb
 
Merle Gerigk
No Relationships to Disclose
 
Juliane Sueptitz
No Relationships to Disclose
 
Florian Kron
No Relationships to Disclose
 
Jan Peter Glossmann
No Relationships to Disclose
 
Reinhard Buettner
No Relationships to Disclose
 
Juergen Wolf
Consulting or Advisory Role - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology; MSD Oncology; Novartis; Pfizer (Inst)
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; MSD Oncology
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Novartis (Inst); Pfizer (Inst); Roche Pharma AG (Inst)